These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 12543802

  • 21. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters.
    Kondo K, Yao M, Yoshida M, Kishida T, Shuin T, Miura T, Moriyama M, Kobayashi K, Sakai N, Kaneko S, Kawakami S, Baba M, Nakaigawa N, Nagashima Y, Nakatani Y, Hosaka M.
    Genes Chromosomes Cancer; 2002 May; 34(1):58-68. PubMed ID: 11921283
    [Abstract] [Full Text] [Related]

  • 22. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schröder JK, Bardenheuer W, Seeber S, Huebner K, Schütte J, Opalka B.
    Cancer Res; 2000 Jun 01; 60(11):2780-5. PubMed ID: 10850413
    [Abstract] [Full Text] [Related]

  • 23. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z.
    Am J Pathol; 1996 Dec 01; 149(6):2089-94. PubMed ID: 8952541
    [Abstract] [Full Text] [Related]

  • 24. A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma.
    Poland KS, Azim M, Folsom M, Goldfarb R, Naeem R, Korch C, Drabkin HA, Gemmill RM, Plon SE.
    Genes Chromosomes Cancer; 2007 Sep 01; 46(9):805-12. PubMed ID: 17539022
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues.
    Petursdottir TE, Thorsteinsdottir U, Jonasson JG, Moller PH, Huiping C, Bjornsson J, Egilsson V, Imreh S, Ingvarsson S.
    Genes Chromosomes Cancer; 2004 Nov 01; 41(3):232-42. PubMed ID: 15334546
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER.
    Cancer Res; 2002 Jul 01; 62(13):3803-11. PubMed ID: 12097293
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE, Tartof KD.
    Cancer Res; 1995 Dec 15; 55(24):6189-95. PubMed ID: 8521412
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes.
    Hughson MD, Meloni A, Dougherty S, Silva FG, Sandberg AA.
    Cancer Genet Cytogenet; 1996 Apr 15; 87(2):133-9. PubMed ID: 8625259
    [Abstract] [Full Text] [Related]

  • 35. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
    Brauch H, Weirich G, Brieger J, Glavac D, Rödl H, Eichinger M, Feurer M, Weidt E, Puranakanitstha C, Neuhaus C, Pomer S, Brenner W, Schirmacher P, Störkel S, Rotter M, Masera A, Gugeler N, Decker HJ.
    Cancer Res; 2000 Apr 01; 60(7):1942-8. PubMed ID: 10766184
    [Abstract] [Full Text] [Related]

  • 36. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
    Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA.
    Hum Mol Genet; 1994 Dec 01; 3(12):2169-73. PubMed ID: 7881415
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Patterns of aneuploidy in stage IV clear cell renal cell carcinoma revealed by comparative genomic hybridization and spectral karyotyping.
    Pavlovich CP, Padilla-Nash H, Wangsa D, Nickerson ML, Matrosova V, Linehan WM, Ried T, Phillips JL.
    Genes Chromosomes Cancer; 2003 Jul 01; 37(3):252-60. PubMed ID: 12759923
    [Abstract] [Full Text] [Related]

  • 39. Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma.
    Barnabas N, Amin MB, Pindolia K, Nanavati R, Amin MB, Worsham MJ.
    J Surg Oncol; 2002 May 01; 80(1):52-60. PubMed ID: 11967908
    [Abstract] [Full Text] [Related]

  • 40. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K, Al-Saleem T, Karbowniczek M, Ewalt D, Prowse AH, Henske EP.
    Mod Pathol; 2002 Mar 01; 15(3):205-10. PubMed ID: 11904337
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.